CCSC

National Hemophilia Foundation

Website provided by National Hemophilia Foundation and its education partners

Evaluation – CCSC Presents: Managing Costs and Clinical Outcomes While Preparing for a Rapidly Changing Therapeutic Landscape

Jointly provided by

Jointly provided by

    

  • CCSC is supported by charitable donations from founding supporter Takeda, and additional support from BioMarin, Biotechnology Innovation Organization, Bleeding & Clotting Disorders Institute, CSL Behring, Genentech, Inc., Gulf States Hemophilia and Thrombophilia Center, Louisiana Center for Bleeding and Clotting Disorders, Sanofi, and Spark Therapeutics.

  • Copay Accumulator Adjustment Program (CAAP) Outreach is supported by AbbVie, Inc.

    © 2023 National Hemophilia Foundation. All rights reserved.

 

Footer Menu